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Background: Herein we report a case of bilateral anterior ischemic optic neuropathy (AION) showing
histopathologic evidence of AL-amyloidosis of the temporal arteries. It is known that light-chain (AL) amyloidosis
may rarely affect the temporal arteries, mimicking giant cell arteritis, while, to our knowledge, the association
between AL-amyloidosis and AION was not previously described.
Case presentation: A 64 year-old woman with AL-amyloidosis secondary to a monoclonal gammopathy of
undetermined significance (MGUS) referred to our hospital for acute painless drop of vision due to bilateral AION.
Age greater than 50 years, high erythrocyte sedimentation rate (ESR), and bilateral AION were suggestive of giant
cell arteritis (GCA). However, a temporal artery biopsy excluded GCA, showing segmental stenosis of the lumen
caused by amyloidosis of the artery wall.
Conclusions: The present case shows that AL-amyloidosis may present with AION, high ESR, and temporal artery
involvement, mimicking GCA. In patients with monoclonal gammopathies, C-reactive protein may be a more
specific index of GCA compared with the ESR. Patient medical history and pathology are crucial for a correct
diagnosis.
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Arteritic Anterior Ischemic Optic Neuropathy (Arteritic-
AION) is one of the most serious complications of giant
cell arteritis (GCA) or Horton’s disease, and it is caused by
the occlusion of the posterior ciliary arteries, supplying
the optic nerve head (ONH) [1]. Arteritic-AION is the
most frequent ophthalmological complication of GCA
(81.2%), followed by central retinal artery occlusion
(14.1%), retrobulbar ischemic optic neuropathy (7%), and
ocular ischemia (1.2%) [1].
Light-chain (AL) amyloidosis, or primary amyloidosis, is
a hematological disease characterized by the deposition in
tissues of monoclonal light-chain variable-region im-
munoglobulin fragments, which may involve any tissue or
organ. It is usually associated with monoclonal gammopathy* Correspondence: neri.mail2@gmail.com
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reproduction in any medium, provided the orof undetermined significance (MGUS) or smoldering
myeloma, less frequently with symptomatic multiple mye-
loma [2]. The vascular system is often involved by the
deposition of the amyloidal-proteins, which principally
affect the small-caliber vessels [2]. The localization to
medium- or large-size vessels is less frequent; nonetheless,
deposits of the amyloidal-protein were found in the
coronary arteries [3], and arterial thromboembolic events
associated with cardiac AL-amyloidosis were reported [4].
AL-amyloidosis of the temporal arteries has also been
shown in patients with symptoms and signs suggestive of
GCA [5-10].
Here we report a case of bilateral AION showing
clinical and laboratory signs suggestive of GCA, which
was subsequently excluded by pathology and further
laboratory findings. Positivity of the temporal artery
biopsy (TAB) for light-chain amyloidosis prompted us to
evaluate the possibility that AL-amyloidosis may be a -. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Case presentation
A 64 year-old woman referred to the emergency service of
our department for acute painless drop of vision. The
patient reported a complete loss of vision in the right eye
and a loss of the inferior visual field in the left eye since
waking up in the morning. Past medical history revealed
AL-amyloidosis secondary to monoclonal gammopathy ofFigure 1 Visual field examination at presentation. Kinetic (upside) and
presentation, showing an altitudinal scotoma affecting the inferior visual fieunknown origin (immunoglobulin G light chain k, IgGk)
with main involvement of kidneys (nephrosic syndrome),
arterial hypertension, and hypercolesterolemia. The diag-
nosis of AL-amyloidosis had been posed two years before
by biopsy of both kidney and periumbilical fat, while
negative bone marrow puncture confirmed MGUS. Dur-
ing the previous year the patient had been treated for
amyloidosis (one week per month, for 8 months) with
dexamethasone (40 mg/day), bortezomib (1.3 mg/m2 two
times weekly), and cyclophosphamide (20 mg/Kg oncestatic (downside) perimetry of the left eye of the patient at
ld. Visual field examination was not executable in the right eye.
Figure 2 Optic nerve head evaluation at one-year of follow-up.
A. Color pictures of the optic nerve head of the right and left eye
of the patient at one-year of follow-up. B. Optical coherence
tomography evaluation of the Retinal Nerve Fiber Layer thickness
(RNFL thickness) at one-year of follow-up, showing relative preservation
of the ganglion cell fibers in the inferior quadrants of the left eye,
compared with the diffuse reduction of RNFL thickness in the right eye.
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suspended because of hepatic toxicity two months before
the presentation of the visual symptoms. At presentation
the patient treatment included omeprazole 20 mg/day,
ramipril 2.5 mg/day, furosemide 100 mg/day, spironolac-
tone 25 mg/every other day, and atorvastatin 20 mg/day.
Lens corrected visual acuity at presentation was light
perception in the right eye and 20/20 in the left eye.
Pupil light reflex examination showed a marked relative
afferent defect (RAPD) of the right eye. Visual field
examination was not executable in the right eye, while
in the left eye it revealed an inferior altitudinal scotoma
(Figure 1). Biomicroscopy showed normal anterior
segment, while at fundoscopy an ONH edema was found
in both eyes: in the right eye the edema involved the
entire ONH, while in the left eye there was limited in-
volvement of the superior half of the ONH, in keeping
with the visual field examination (Figure 1).
Blood analyses were performed at presentation, re-
vealing abnormally high erythrocyte sedimentation rate
(ESR = 78 mm/h, laboratory range 2-30 mm), as well as
high serum levels of both fibrinogen (745 mg/dL, labora-
tory range 150-400 mg/dL) and D-dimer (331 ng,
laboratory range 0-245 ng). Serum levels of C-reactive
protein were within the normal range (CRP = 0.41 mg/dL,
laboratory range 0.001-5.0 mg/dL). Recent medical history
was negative for claudicatio mandibularis or temporal
tenderness.
The patient was admitted to the rheumatology service
of our hospital for suspect silent GCA, and high dose
corticosteroid therapy was immediately started (1 g
methilprednisolone/day i.v. in the first three days, then
oral prednisone 50 mg/day). The patient did not report
any change of the visual symptoms after starting the
corticosteroid therapy. A brain MRI was performed three
days after presentation, showing bilateral optic nerve head
thickening and multiple chronic ischemic lacunae in sub-
cortical and profound white matter. The ultrasound
study of the temporal arteries showed tortuosity and
segmental stenosis of the arterial lumen, without sig-
nificant limitation of the blood flow. Ultrasound mor-
phologic alterations typical of GCA (hypo-ecogenic
concentric mural thickening) were not found. Carotid
Doppler-ultrasound did not identify significant alter-
ations of blood flow.
A biopsy of the right temporal artery was obtained
and analyzed histopathologically ten days after presenta-
tion, showing diffuse mural infiltration of amyloidal
substance, causing the segmental stenosis of the arterial
lumen. The amyloid substance showed immunologic
positivity for immunoglobulin k light chains and for
amyloidal P-substance, and the tunica intima was thick-
ened by fibrosis and calcific deposits, with subocclusion
of the vessel. No pathologic signs of GCA were found.Acetylsalicylic acid 100 mg/day p.o. was consequently
started, and steroids were slowly tapered.
An ophthalmological evaluation was repeated one
month and one year after presentation. At one-month
the ONH edema had almost disappeared, and just a
slight masking of the peripapillary vessels was noticeable.
At one-year a pallid atrophic ONH was observed in the
right eye, and sector atrophy of the ONH was present in
the left eye (Figure 2A). Optical coherence tomography
(OCT) study of the retinal nerve fiber layer (RNFL)
showed a uniformly reduced thickness of the retinal
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reduction of RFNL thickness in the inferior quadrants in
the left eye (Figure 2B). Visual acuity and visual field
examination remained stable during the follow-up.
Conclusions
The case herein described presented a problematic
differential between arteritic (AAION) and non-arteritic
anterior optic neuropathy (NAION). In fact, age greater
than fifty years, bilateral eye involvement, and high ESR at
presentation were suggestive of a diagnosis of AAION.
However, a high ESR is a common laboratory finding in
patients with serous monoclonal gammopathies [11],
hence its specificity for the diagnosis of AAION may be
scarce in these patients. CRP values, instead, were within
the normal range in the present case, suggesting that CRP
could be a more specific index of AAION in patients with
coexisting plasma cell dyscrasias.
The TAB excluded the diagnosis of GCA in the present
case, showing diffuse amyloid infiltration of the artery
wall. A possible hypothesis explaining the pathogenesis of
the optic nerve head ischemia is that the AL-amyloid
deposition found in the temporal artery specimen may
also have affected the posterior ciliary arteries, causing
arterial stenosis and insufficiency, or reduced adaptability
to blood pressure variations. As the pathological processes
characteristics of GCA commonly involve the posterior
ciliary arteries, it is possible that the arteries of this district
share with the temporal arteries common histological
features causing their preferential susceptibility to GCA.
Similarly, the posterior ciliary arteries could share with the
temporal arteries a common susceptibility to the depos-
ition of amyloid substance. High blood viscosity due to
MGUS, arterial hypertension, and hypercholesterolemia
were other factors increasing the risk of NAION in
our patient.
The presentation of AION at the awakening in the
morning further supports this hypothesis. In fact, blood
pressure dips are more commonly encountered during
the night, and they are associated to a higher risk of
NAION [12-14]. The arterial stenosis combined with a
hypotensive dip of the arterial blood pressure could
have caused bilateral optic nerve head ischemia in
our patient.
AION is rarely bilateral at its exordium [15]. In the
present case it can’t be excluded that the patient was not
aware of a preexistent monolateral AION until the
contralateral eye was involved. However, the appearance
of the optic discs at presentation was symmetrical, and
indicative for a recent exordium of the ischemia in both
the eyes.
Maybe fluorescein angiography (FA) could have pro-
vided useful elements for the diagnosis and characteri-
zation of the present clinical case. Unfortunately, in ourhospital FA is not performed routinely in patients with
diagnosis of AION, relying on TAB findings for diffe-
rential diagnosis between AAION and NAION. When the
patient was controlled after the TAB response one month
had passed from presentation and the ONH edema had
partially regressed, hence it was decided not to perform
the angiography.
In conclusion, the present case shows that AL-
amyloidosis may present with bilateral AION, mimicking
giant cell arteritis not only for the visual symptoms, but
also for high ESR values and temporal artery involve-
ment. Moreover, AL-amyloidosis and giant cell arteritis
might share similar pathogenetical mechanisms, leading
to affect the same small arterial districts. Patient medical
history and pathology are crucial for a correct diagnosis.
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